Cameco Corp. Stock
€91.20
Your prediction
Cameco Corp. Stock
Pros and Cons of Cameco Corp. in the next few years
Pros
Cons
Performance of Cameco Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cameco Corp. | 1.650% | -7.084% | -14.877% | 69.219% | 13.283% | 213.487% | 410.063% |
| Laramide Resources Ltd | 0.000% | -8.881% | -17.537% | -5.615% | 19.335% | 37.871% | 10.799% |
| Blue Sky Uranium Corp. | -3.330% | -1.316% | -12.281% | -5.063% | 17.188% | -48.276% | -79.592% |
| Green Thumb Industries Inc. | 0.840% | 4.234% | 0.847% | 56.716% | 6.567% | 2.586% | -71.210% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.When examining the financials of Cameco Corporation (US symbol: CCJ), which operates in the uranium industry, a nuanced picture emerges. The company’s financial statements indicate healthy revenue generation but also present challenges, particularly regarding profitability margins and significant debt levels. As a leader in uranium production, Cameco is well-positioned in a sector that is increasingly gaining attention due to renewed interest in nuclear energy. However, as any thorough analysis will reveal, the implications of the financial ratios require a closer look.
Strong Revenue Base: Cameco has reported a total revenue of CAD 2.59 billion for 2023, indicating solid operational performance. The revenue generation reflects the company's robust demand and market position within the uranium sector, which is attractive for growth potential.
Positive EBITDA Figures: The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) stands at CAD 502 million. This figure underscores the operational efficiency of Cameco, suggesting that the company can generate substantial earnings from its core activities. A healthy EBITDA is often viewed as an indicator of a firm's profitability before non-operational expenses are factored in.
Comments
News
3 Reasons to Buy Cameco Stock Like There's No Tomorrow
Ready to reload your portfolio with something other than another overpriced AI technology stock? If so, you're not alone. The artificial intelligence opportunity is real, but stepping into its most
The Top 2 Nuclear Energy Stocks to Buy Right Now
The nuclear energy market cooled for roughly a decade after the Fukushima disaster in 2011, prompting many countries to pause their nuclear projects. But over the past few years, new decarbonization
2 Nuclear Stocks That Are Quietly Becoming the Trade of the Year (and Beyond)
Global energy demand is exploding, and the world is facing a simple reality: We need more energy. While wind and solar have grown in popularity, modern technology is always on and needs reliable